UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-QSB
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended September 30, 1998
---------------------------------------------
Commission file number 0-19170
JUNIPER GROUP, INC.
-------------------------------------------------------------------------------
(Exact name of small business issuer as specified in its charter)
Nevada 11-2866771
- -------------------------------------------------------------------------------
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
111 Great Neck Road, Suite 604, Great Neck, New York 11021
- --------------------------------------------------------------------------------
(Address of principal executive offices)
(516) 829-4670
- --------------------------------------------------------------------------------
(Issuer's telephone number)
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes X No
--- ---
The number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date, November 10, 1998, was 2,177,824
shares of common stock - $.001 par value.
Transitional Small Business Disclosure Format: Yes No X
--- ---
1
<PAGE>
PART I - FINANCIAL INFORMATION
ITEM 1: Financial Statements
JUNIPER GROUP, INC.
AND SUBSIDIARY COMPANIES
CONSOLIDATED BALANCE SHEETS
September December
Assets 30, 1998 31, 1997
----------- -----------
Current Assets
Cash ........................................... $ 19,083 $ 30,187
Accounts receivable - trade .................... 779,016 363,480
Due from affiliates ............................ 9,180 15,570
Due from officer ............................... 93,602 -
Prepaid expenses and other current assets ...... 216,311 141,098
----------- -----------
Total current assets ....................... 1,117,192 550,335
Film licenses .................................. 2,939,792 2,954,562
Property and equipment net of accumulated
depreciation of $71,692 and $127,382
respectively ................................. 64,310 98,911
Other assets ................................... 168,540 2,049
----------- -----------
$ 4,289,834 $ 3,605,857
=========== ===========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable and accrued expenses .......... $ 1,039,747 $ 835,427
Notes payable - current ........................ 444,005 342,571
Due to producers - current ..................... 29,586 62,086
Due to officer ................................. 16,398 68,662
Due to shareholders ............................ 7,000 7,000
----------- -----------
Total current liabilities ................. 1,520,338 1,315,746
Due to producers - long term ..................... 62,496 93,814
----------- -----------
Total liabilities ......................... 1,582,834 1,409,560
----------- -----------
Shareholders' Equity
12% Non-voting convertible redeemable
preferred stock: $.10 par value, 875,000
shares authorized, 235,900 shares issued
and outstanding at September 30, 1998, and
December 31, 1997: aggregate liquidation
preference, $471,800 at September 30, 1998
and December 31, 1997 ......................... 23,590 23,590
Common Stock - $.001 par value, 6,000,000
shares authorized, 2,081,526 and 759,915
issued and outstanding at September 30, 1998
and December 31, 1997, respectively ........... 2,082 760
Capital contributions in excess of par:
Attributed to preferred stock ................. 210,303 210,303
Attributed to common stock .................... 9,231,189 7,971,979
Retained earnings (deficit) .................... (6,760,164) (6,010,335)
----------- -----------
Total shareholders' equity .................... 2,707,000 2,196,297
----------- -----------
$ 4,289,834 $ 3,605,857
=========== ===========
See Notes to Consolidated Financial Statements
2
<PAGE>
JUNIPER GROUP, INC.
AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended
September 30, September 30,
1998 1997
------------ ------------
Revenues:
Healthcare .............................. $ 457,342 $ 291,655
Entertainment ........................... 36,000 20,000
------------ ------------
493,342 311,655
------------ ------------
Operating Costs:
Healthcare .............................. 45,759 164,306
Entertainment ........................... 15,670 8,883
Selling, general and administrative expenses . 432,403 511,192
------------ ------------
493,832 684,381
------------ ------------
Net income (loss) before income (expense)
from minority interest...................... (490) (372,726)
Income (expense) from minority interest....... (31,277) -
------------- ------------
Net income (loss) ............................ $ ( 31,767) (372,726)
============ ============
Weighted average number of shares outstanding 1,812,035 493,324
============ ============
Net income (loss) per common share $ (0.03) $ (0.78)
============ ============
See Notes to Consolidated Financial Statements
3
<PAGE>
JUNIPER GROUP, INC.
AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENTS OF INCOME
Nine Months Ended
September 30, September 30,
1998 1997
------------ ------------
Revenues:
Healthcare .............................. $ 949,921 $ 1,090,236
Entertainment ........................... 46,000 20,000
------------ ------------
995,921 1,110,236
Operating Costs:
Healthcare .............................. 102,217 465,385
Entertainment ........................... 17,963 8,883
Selling, general and administrative expenses . 1,327,057 1,373,371
Settlement Expense 267,236 -
------------ ------------
1,714,473 1,847,639
Net income (loss) before income (expense)
from minority interest...................... (718,522) (737,403)
Income (expense) from minority interest....... (31,277) -
------------- ------------
Net income (loss) ............................ $ (749,829) $ (737,403)
============ ============
Weighted average number of shares outstanding 1,273,834 436,013
============ ============
Net income (loss) per common share $ (0.62) $ (1.79)
============ ============
See Notes to Consolidated Financial Statements
4
<PAGE>
JUNIPER GROUP, INC.
AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended
September 30, September 30,
1998 1997
------------ ------------
Operating Activities
Net income (loss) ............................ $ (749,829) $ (737,403)
Adjustments to reconcile net cash provided
by operating activities:
Amortization expense......................... 14,770 8,883
Depreciation expense ........................ 8,377 30,342
Settlement Expense .......................... 267,236 -
Gain on disposition of assets ............... (6,362) -
Expense from minority interest 31,277 -
Payment of officer's compensation with equity 236,718 51,713
Payment of various liabilities with equity .. 182,263 112,815
Payment of directors compenations with equity 35,250 18,000
Payment of employees compensation with equity 48,750
Changes in assets and liabilities:
Accounts receivable ......................... (415,536) 24,804
Prepaid expenses and other current assets ... 8,120 (12,962)
Other assets ................................ (1,690) 245
Due to/from officers and shareholders........ (52,264) 38,112
Due from affiliates ......................... (24,887) 17,717
Accounts payable and accrued expenses ....... 94,321 282,755
------------ ---------
Net cash provided from (used for)
operating activities ....................... (372,236) (116,229)
------------ ---------
Investing activities:
Sale (purchase) of equipment ................ (5,250) -
------------ ---------
Financing activities:
Reduction in borrowings ..................... (204,800) (110,320)
Proceeds from borrowings .................... 485,000 262,500
Payments to and on behalf of producers ...... (63,818) (89,856)
Proceeds from exercise of options ........... - 54,850
Proceeds from private placements ............ 150,000 88,600
----------- ---------
Net cash provided from (used for)
financing activities ...................... 366,382 205,774
----------- ---------
Net increase (decrease) in cash ............. (11,104) 89,545
Cash at beginning of period ................. 30,187 14,593
----------- ---------
Cash at end of period ....................... $ 19,083 $ 104,138
=========== =========
Supplemental cash flow information:
Interest paid .............................. $ 18,928 $ 6,909
----------- ---------
See Notes to Consolidated Financial Statements
5
<PAGE>
JUNIPER GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 - Basis of Presentation:
The interim consolidated financial statements included herein have been prepared
without audit, pursuant to the rules and regulations of the Securities and
Exchange Commission ("SEC"). Certain information and footnote disclosures,
normally included in the financial statements prepared in accordance with
generally accepted accounting principles, have been condensed or omitted
pursuant to SEC rules and regulations; nevertheless, management of the Company
believes that the disclosures herein are adequate to make the information
presented not misleading. The consolidated financial statements and notes should
be read in conjunction with the audited consolidated financial statements and
notes thereto as of December 31, 1997 included in the Company's Form 10-KSB
filed with SEC.
In the opinion of management, all adjustments consisting only of normal
recurring adjustments necessary to present fairly the consolidated financial
position of the Company with respect to the interim consolidated financial
statements have been made. The results of operations for the interim periods are
not necessarily indicative of the results to be expected for the full year.
6
<PAGE>
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The following discussion and analysis of financial condition and results of
operations should be read in conjunction with the Company's consolidated
financial statements and notes thereto included elsewhere herein. The statements
disclosed herein include forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section 21E of the
Securities Exchange Act of 1934, as amended. the Company's actual results could
differ materially from those projected in the forward-looking statements as a
result of certain risks and uncertainties, including, but not limited to, the
Company's historical lack of profitability, the Company's need for additional
financing, competition in the managed health care industry, and other risks
detailed from time to time in the Company's filings with the Securities and
Exchange Commission.
OVERVIEW
- --------
Juniper Group, Inc. (the "Company")is a Nevada Corporation. Its principal
businesses are composed of two segments, healthcare and entertainment: (i) the
healthcare operations are conducted through two subsidiaries of Juniper Medical
Systems, Inc. ("JMSI"), which is a wholly owned subsidiary of the Company: (a)
PartnerCare, Inc. ("PCI"), a managed care revenue enhancement company providing
various types of services such as: Physician Practice Management, Managed Care
Revenue Enhancement, Comprehensive Pricing Reviews, MSOs and Liability
Assessment Programs to newly evolving integrated hospital and physician markets
and (b) Juniper Healthcare Containment Systems, Inc. ("Containment"), which
develops and provides full service healthcare networks for insurance companies
and managed care markets in the Northeast U.S.; and (ii) the entertainment
segment is conducted principally through Juniper Pictures, Inc. ("Pictures"), a
wholly owned subsidiary of Juniper Entertainment, Inc. ("JEI"), a wholly owned
subsidiary of the Company, which engages in the acquisition, exploitation and
distribution of rights to films to the various media (i.e., home video, pay-per
view, pay television, cable television, networks and independent syndicated
television stations) in the domestic and foreign marketplace. The Company's
operations are based at 111 Great Neck Road, Suite 604, Great Neck, New York
11021.
As part of its services to physician groups, JMSI is developing a new business
that will seek to offer physicians the capability to provide advanced nuclear
cardiac testing in the convenience of their office. This business, Nuclear
Cardiac Imaging, Inc. ("NCI"), is owned 49% by JMSI and is reflected as a
minority interest in the Company's financial statements.
Year 2000
- ---------
the Company has completed the process of becoming year 2000 compliant. All of
the Company's systems have been updated so that none of its systems will be
affected by the Year 2000. This process cost the Company less than $5,000.
the Company is in the process of identifying and contacting the hospitals it
services to determine the extent to which the Company's business may be affected
by those third parties failure to remedy their own Year 2000 issues. It is
expected that full identification will be completed by March 31, 1999. The
company does not currently have any formal information concerning the Year 2000
compliance status of the hospitals it services but has received indications that
most of the hospitals are working on Year 2000 compliance. In the event that any
of the significant hospitals that the Company services do not successfully and
timely achieve Year 2000 compliance, the Company's business or operations could
be adversely affected.
7
<PAGE>
RESULTS OF OPERATIONS
- ---------------------
Three Months Ended September 30, 1998 vs Three Months Ended September 30, 1997
- --------------------------------------------------------------------------------
Revenue related to the Healthcare segment increased to $457,000 in the third
quarter of 1998 from $292,000 in the third quarter of 1997, representing a 57%
increase. The increase in revenue during the third quarter of 1998 was
predominately attributed to PCI. PCI's revenue increased to $399,000 in 1998,
from $101,000 in 1997. This was the result of PCI's success in marketing its new
Managed Care Revenue Enhancement Program, resulting in a growing number of
hospital clients. Revenue from Containment decreased to $58,000 in the third
quarter of 1998, compared to approximately $190,000 in the third quarter of
1997, a 69% decrease. This is a result of changes instituted in December 1997,
whereby Containment discontinued a joint venture arrangement, and the joint
ventures arrangements with the Guardian Insurance Company. The loss of this
business has been temporarily replaced with a settlement agreement involving the
joint venture, which will generate revenue with no corresponding expense
throughout 1998.
The entertainment segment recognized revenue of $36,000 in the third quarter of
1998, and $20,000 in the third quarter of 1997. Certain of the Company's films
that generated revenue when the contracts were signed are still under license,
and are currently being aired by the licensees. The Company is currently
utilizing significant resources to build the healthcare segment of its business,
and has not devoted resources toward the promotion and solicitation of the films
in 1997. However, the Company has begun looking for outside salesmen to help
market and marchandise the films that are not currently under license.
Healthcare operating costs decreased to $46,000 in the third quarter of 1998
from $164,000 in the third quarter of 1997, a 72% decrease. As a percentage of
revenue, operating costs of the healthcare operations decreased to 10% in the
third quarter of 1998 from 56% in the third quarter of 1997. The decrease is due
to the fact that operating costs for Containment were lower because of the new
Settlement Agreement in connection with the discontinued joint venture
arrangement.
Selling, general and administrative expenses decreased to $432,000 in the third
quarter of 1998 from $511,000 in the third quarter of 1997, a 15% decrease. This
change is primarily due to increases in consulting fees of $20,000, salaries and
related taxes of $7,000, legal expense of $10,000, interest of $10,000,
commissions of $37,000, other office expense of $3,000, offset by a reduction of
travel expenses of $7,000, public relations expense of $87,000, bad debt expense
of $30,000, insurance of $20,000 and depreciation and amortization of $22,000.
Most of the increase was related to the management changes in PCI during 1997
and the corresponding redirection of time and resources of management
initiatives to re-engineer and diversify product lines through the development
of the new information systems.
RESULTS OF OPERATIONS
- ---------------------
Nine Months Ended September 30, 1998 vs Nine Months Ended September 30, 1997
- --------------------------------------------------------------------------------
Revenue related to the Healthcare segment decreased to $950,000 through the
third quarter of 1998 from $1,090,000 through the third quarter of 1997,
representing a 13% decrease. The decrease in revenue through the third quarter
of 1998 was predominately attributed to Containment, which had revenue of
approximately $220,000 through the third quarter of 1998, compared to
approximately $658,000 in the third quarter of 1997, a 67% decrease. This is a
result of changes instituted in December 1997, whereby Containment discontinued
a joint venture arrangement, and the joint ventures arrangements with the
Guardian Insurance Company. The loss of this business has been temporarily
replaced with a settlement agreement involving the joint venture, which will
generate revenue with no corresponding expense throughout 1998. PCI's revenue
increased to $730,000 in 1998, from $432,000 in 1997, a 69% increase. This was
the result of PCI's change in direction from a DRG audit company to a Managed
Care Revenue Enhancement company.
The entertainment segment recognized $46,000 in revenue through the third
quarter of 1998, and $20,000 through the third quarter of 1997. Certain of the
Company's films that generated revenue when the contracts were signed are still
under license, and are currently being aired by the licensees. the Company is
currently utilizing significant resources to build the healthcare segment of its
business, and has not devoted resources toward the promotion and solicitation of
the films in 1997. However, the Company has begun looking for outside salesmen
to help market and marchandise the films that are not currently under license.
8
<PAGE>
Healthcare operating costs decreased to $102,000 through the third quarter of
1998 from $465,000 in the third quarter of 1997, a 78% decrease. As a percentage
of revenue, operating costs of the healthcare operations decreased to 11%
through the third quarter of 1998 from 43% through the third quarter of 1997.
The decrease is due to the fact that operating costs for Containment were lower
because of the new Settlement Agreement in connection with the discontinued
joint venture arrangement.
Selling, general and administrative expenses decreased to $1,327,000 through the
third quarter of 1998 from $1,373,000 through the third quarter of 1997, a 3%
decrease. This change is primarily due to increases in bad debt expense of
$40,000(due to a more conservative evaluation of the Company's accounts
receivable), Director's Compensation expense of $16,000, consulting fees of
$39,000, commissions of $37,000, interest of $26,000, and rent of $11,000,
offset by a reduction of public relations expenses of $75,000, insurance of
$20,000, depreciation of $22,000, office expense of $13,000, telephone expense
of $15,000, salaries of $52,000 and SEC costs of $18,000 . Most of this decrease
was related to the management changes in PCI during 1997 and the corresponding
redirection of time and resources of management initiatives to re-engineer and
diversify product lines through the development of the new information systems.
LIQUIDITY AND CAPITAL RESOURCES
- -------------------------------
Working capital deficiency at September 30, 1998 was $403,000, compared to
working capital deficiency of $765,000 at December 31, 1997. The ratio of
current assets to current liabilities was .73:1 at September 30, 1998 and .42:1
at December 31, 1997. Cash flow used in operations during the third quarter of
1998 was $372,000, compared to cash flow used in operations during the third
quarter of 1997, of $116,000.
Accounts receivable - trade increased to $799,000 from $363,000 at December 31,
1997.
Accounts payable increased to $1,040,000 from $835,000 at December 31, 1997.
Although the Company plans to continue to expand its healthcare business to the
extent that resources are available, the Company has no firm material
commitments for capital expenditures in other areas of its business and has no
plans to acquire additional films.
The Company believes that it may not have sufficient liquidity to meet its
operating cash requirements for the current level of operations during the
remainder of 1998. the Company will require additional financing. There can be
no assurance that financing will be available, or if available, on terms
acceptable to the Company. If the Company is unable to fund its operating cash
flow needs, the Company may be required to substantially curtail operations.
the Company currently does not have any bank lines of credit.
At the Company's annual meeting held on February 12, 1997, management eliminated
shareholders' pre-emptive rights, which previously existed under New York law.
Notwithstanding these rights, the Company has on a number of occasions, prior to
the elimination of those pre-emptive rights, issued shares without affording
shareholders the opportunity to exercise pre-emptive rights and without
procuring waivers of such rights. No shareholder has alleged any damage
resulting to him as a result of the sale of shares by the Company without
offering pre-emptive rights. The amount of damages incurred by shareholders by
reason of the failure of the Company to offer pre-emptive rights, if any, is not
ascertainable with any degree of accuracy. Management believes that if claims
were asserted alleging damages, the Company may have valid defenses.
9
<PAGE>
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
-----------------
On April 17, 1998, Juniper Group, Inc., a Nevada corporation (the
"Registrant"), entered into a Stipulation of Settlement (the "Settlement") to
settle a lawsuit (the "Action") by Ordinary Guy, Inc. and Crow Productions, Inc.
(the "Plaintiffs") against the Registrant, Juniper Pictures, Inc., Juniper
Entertainment, Inc., and Vlado P. Hreljanovic that was pending in the United
States District Court for the Eastern District of New York, Case No.: 96 Civ.
2542 (the "Lawsuit"). Under the terms of the Settlement, Registrant agreed to
pay a total of $310,000 to the plaintiffs as follows: $50,000 in cash, payable
on or before April 20, 1998; $10,000 in cash, payable on or before May 20, 1998;
and $250,000 by a promissory note, secured and funded by 93,320 shares of the
Registrant's common stock, $.001 par value, to be held in escrow jointly by
counsel for the parties, providing for three equal payments of $83,333.33 due on
April 21, 1999, April 21, 2000 and April 21, 2001 (The "Payment Dates").
Payments under the Note shall be funded by 93,320 shares of the Registrant's
common stock, $.001 par value (the "Juniper Shares"), to be held in escrow
jointly by counsel for the parties. On each successive Payment Date, one third
of the Juniper Shares shall be released from the escrow and sold in order to
make the payment then due. Any proceeds from such sale in excess of $83,333.33
shall be applied to the next payment due under the Note. In the event that the
Note is satisfied in full prior to April 21, 2001, the remaining Juniper shares
in escrow shall be released to and retained by Plaintiffs. In the event that the
proceeds from such sale are insufficient to make a payment when due, registrant
shall be responsible for paying any deficiency. Upon full satisfaction of the
payment provisions of the Settlement, the Action will be dismissed with
prejudice and each of the defendants will be released by Plaintiffs from any
claims or liabilities that were or could have been asserted in the Action.
Item 2. Changes in Securities
-----------------------
(a) N/A
(b) N/A
(c) Common Stock, $0.001 par value, sold and or issued through the third quarter
of 1998 were as follows:
<TABLE>
<CAPTION>
Date Purchaser Amount (#) Amt. Paid ($) Description Exemption
- -------------------- ------------------ ------------------- ------------------ ------------------- -----------------
<S> <C> <C> <C> <C> <C> <C>
1/1-9/30/98 Officers 204,606 236,718 (1) 4(2)
3/1-9/30/98 Vendors 284,889 182,263 (2) 4(2)
1/1-4/3/98 Reg S 148,721 806,300 (3) Reg. S
6/30/98 Directors 47,000 35,250 (4) 4(2)
7/23-9/11/98 Debenture 522,667 306,300 (5) 4(2)
7/1/98 Settlement of Lawsuit 93,320 250,000 (See Item 1 above) 4(2)
</TABLE>
_______________________
(1) The President and CEO of the Company accepted common stock in lieu of
cash compensation for salary and bonuses.
(2) Vendors accepted common stock in lieu of unpaid fees.
(3) Non-U.S. consultants accepted common stock in lieu of consulting fees
relating to public relations services provided to the Company.
(4) The Board of Directors accepted common stock in lieu of cash compensation.
(5) Three Debenture Offerings: one for $250,000, one for $50,000 and one for
$6,300.
10
<PAGE>
Item 3. Defaults Upon Senior Securities
---------------------------------
Preferred Stockholders are entitled to receive from assets legally available for
payment a dividend at a rate of 12% per annum of the Preferred Stock liquidation
preference of $2.00 (or $.24 per annum) per share, payable quarterly on March 1,
June 1, September 1 and December 1, in cash or in shares of Common Stock having
an equivalent fair market value. Unpaid dividends on the Company's Preferred
Stock cumulate. The quarterly payments due on September 1 and December 1, 1992,
and all payments due in 1993, in 1994, in 1995, in 1996, in 1997 and the
payments due on March 1, June 1, and September 1, 1998 have not yet been paid
and are accumulating. These dividends have not been declared because earned
surplus is not available to pay a cash dividend. Accordingly, dividends will
accumulate until such time as earned surplus is available to pay a cash dividend
or until a post effective amendment to the Company's registration statement
covering a certain number of common shares reserved for the payment of Preferred
Stock dividends is filed and declared effective, or if such number of common
shares are insufficient to pay cumulative dividends, then until additional
common shares are registered with the Securities and Exchange Commission (SEC).
No dividends shall be declared or paid on the Common Stock (other than a
dividend payable solely in shares of Common Stock) and no Common Stock shall be
purchased, redeemed or acquired by the Company unless full cumulative dividends
on the Preferred Stock have been paid or declared, or cash or shares of Common
Stock have been set apart which is sufficient to pay all dividends accrued on
the Preferred Stock for all past and then current dividend periods.
As stated above, pursuant to the terms of the Preferred Stock, the Company has
the option of making quarterly dividend payments in cash or shares of Common
Stock. the Company does not intend to make any Preferred Stock dividends in cash
in the foreseeable future. Prospectively, subject to the Company's Prospectus
being current, and a sufficient number of common shares being registered with
the SEC, the Company anticipates making quarterly dividend payments in shares of
Common Stock for the foreseeable future including the payments which have not
yet been made. The total cash value of the arrearage of unpaid dividends is
$354,000.
Item 6. Exhibits and Reports on Form 8-K
--------------------------------
(a) Exhibits
Exhibit Description
3.1 Certificate of Incorporation of the Registrant, as amended (1)
3.2 Amendment to the Certificate of Incorporation of the Registrant, filed
March 7, 1998 (2)
3.3 Certificate of Incorporation of Juniper Group, Inc., a Nevada
corporation.(3)
3.4 By-Laws of the Registrant (1)
3.5 Amendment to the By-Laws of the Registrant approved by the shareholders
of the Registrant on February 12, 1998 (3)
3.6 By-Laws of Juniper Group, Inc., a Nevada corporation (3)
27.1 Financial Data Schedule
- ---- -----------------------
(1) Incorporated by reference to the Company's Annual Report on Form 10-KSB
for the fiscal year ended December 31, 1995
(2) Incorporated by reference to the Company's Annual Report on Form 10-KSB
for the fiscal year ended December 31, 1997
(3) Incorporated by reference to the Company's Proxy Statement for its
Annual Meeting held in February 1998
(b) Reports on Form 8-K.
(1) the Company filed a Form 8-K on April 1, 1998, relating to the sale of
equity pursuant to Regulation S.
(2) The Company filed a Form 8-K on April 28, 1998, relating to the
the Stipulation of Settlement, Ordinary Guy, Inc. and Crow Productions,
Inc. against the Registrant.
(3) the Company filed a Form 8-K on May 18, 1998, relating to a
one-for-fifty reverse stock split, effective at the close of business
on May 18, 1998.
11
<PAGE>
SIGNATURES
In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed by the undersigned, thereunto duly authorized.
JUNIPER GROUP, INC.
Date: , 1998
By:/s/ Vlado P. Hreljanovic
------------------------
Vlado P. Hreljanovic
Chairman of the Board, President,
Chief Executive Officer and Acting
Chief Financial Officer
12
<PAGE>
EXHIBIT INDEX
Exhibit Description
27.1 Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FOUND ON PAGES
3 & 4 OF THE COMPANY'S FORM 10-QSB FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1998.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-mos
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-START> JAN-01-1998
<PERIOD-END> SEP-30-1998
<CASH> 19,083
<SECURITIES> 0
<RECEIVABLES> 779,016
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 1,023,590
<PP&E> 136,002
<DEPRECIATION> 71,692
<TOTAL-ASSETS> 4,196,232
<CURRENT-LIABILITIES> 1,426,736
<BONDS> 0
0
23,590
<COMMON> 2,082
<OTHER-SE> 2,681,328
<TOTAL-LIABILITY-AND-EQUITY> 2,707,000
<SALES> 0
<TOTAL-REVENUES> 995,921
<CGS> 0
<TOTAL-COSTS> 1,714,473
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (749,829)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (749,829)
<EPS-PRIMARY> (.62)
<EPS-DILUTED> (.62)
</TABLE>
